BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 35193647)

  • 1. Overexpressed integrin alpha 2 inhibits the activation of the transforming growth factor β pathway in pancreatic cancer via the TFCP2-SMAD2 axis.
    Cai H; Guo F; Wen S; Jin X; Wu H; Ren D
    J Exp Clin Cancer Res; 2022 Feb; 41(1):73. PubMed ID: 35193647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpressed ITGA2 promotes malignant tumor aggression by up-regulating PD-L1 expression through the activation of the STAT3 signaling pathway.
    Ren D; Zhao J; Sun Y; Li D; Meng Z; Wang B; Fan P; Liu Z; Jin X; Wu H
    J Exp Clin Cancer Res; 2019 Dec; 38(1):485. PubMed ID: 31818309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-323-3p inhibits cell invasion and metastasis in pancreatic ductal adenocarcinoma via direct suppression of SMAD2 and SMAD3.
    Wang C; Liu P; Wu H; Cui P; Li Y; Liu Y; Liu Z; Gou S
    Oncotarget; 2016 Mar; 7(12):14912-24. PubMed ID: 26908446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quercetin suppresses pancreatic ductal adenocarcinoma progression via inhibition of SHH and TGF-β/Smad signaling pathways.
    Guo Y; Tong Y; Zhu H; Xiao Y; Guo H; Shang L; Zheng W; Ma S; Liu X; Bai Y
    Cell Biol Toxicol; 2021 Jun; 37(3):479-496. PubMed ID: 33070227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The TGF-β/Smad
    Yu ZL; Liu J; Ning ZK; Tian HK; Wu X; Huang YF; Wu ZC; Zong Z; Zhou TC
    Mol Carcinog; 2023 Feb; 62(2):261-276. PubMed ID: 36345938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TGF-beta downregulates PTEN via activation of NF-kappaB in pancreatic cancer cells.
    Chow JY; Ban M; Wu HL; Nguyen F; Huang M; Chung H; Dong H; Carethers JM
    Am J Physiol Gastrointest Liver Physiol; 2010 Feb; 298(2):G275-82. PubMed ID: 19940030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TFCP2 activates beta-catenin/TCF signaling in the progression of pancreatic cancer.
    Yuedi D; Yuankun C; Jiaying Z; Han L; Yueqi W; Houbao L; Dexiang Z
    Oncotarget; 2017 Sep; 8(41):70538-70549. PubMed ID: 29050300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ITGA2, LAMB3, and LAMC2 may be the potential therapeutic targets in pancreatic ductal adenocarcinoma: an integrated bioinformatics analysis.
    Islam S; Kitagawa T; Baron B; Abiko Y; Chiba I; Kuramitsu Y
    Sci Rep; 2021 May; 11(1):10563. PubMed ID: 34007003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulating pancreatic cancer microenvironment: The efficacy of Huachansu in mouse models via TGF-β/Smad pathway.
    Wang Y; Zhang A; Li Q; Liu C
    J Ethnopharmacol; 2024 May; 326():117872. PubMed ID: 38325667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissecting the role of TGF-beta type I receptor/ALK5 in pancreatic ductal adenocarcinoma: Smad activation is crucial for both the tumor suppressive and prometastatic function.
    Schniewind B; Groth S; Sebens Müerköster S; Sipos B; Schäfer H; Kalthoff H; Fändrich F; Ungefroren H
    Oncogene; 2007 Jul; 26(33):4850-62. PubMed ID: 17297450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-stroma TGF-β1-THBS2 feedback circuit drives pancreatic ductal adenocarcinoma progression via integrin α
    Nan P; Dong X; Bai X; Lu H; Liu F; Sun Y; Zhao X
    Cancer Lett; 2022 Mar; 528():59-75. PubMed ID: 34958892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A tale of two proteins: differential roles and regulation of Smad2 and Smad3 in TGF-beta signaling.
    Brown KA; Pietenpol JA; Moses HL
    J Cell Biochem; 2007 May; 101(1):9-33. PubMed ID: 17340614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome-wide DNA methylation patterns in pancreatic ductal adenocarcinoma reveal epigenetic deregulation of SLIT-ROBO, ITGA2 and MET signaling.
    Nones K; Waddell N; Song S; Patch AM; Miller D; Johns A; Wu J; Kassahn KS; Wood D; Bailey P; Fink L; Manning S; Christ AN; Nourse C; Kazakoff S; Taylor D; Leonard C; Chang DK; Jones MD; Thomas M; Watson C; Pinese M; Cowley M; Rooman I; Pajic M; ; Butturini G; Malpaga A; Corbo V; Crippa S; Falconi M; Zamboni G; Castelli P; Lawlor RT; Gill AJ; Scarpa A; Pearson JV; Biankin AV; Grimmond SM
    Int J Cancer; 2014 Sep; 135(5):1110-8. PubMed ID: 24500968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pancreatic cancer-associated retinoblastoma 1 dysfunction enables TGF-β to promote proliferation.
    Gore AJ; Deitz SL; Palam LR; Craven KE; Korc M
    J Clin Invest; 2014 Jan; 124(1):338-52. PubMed ID: 24334458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KLF11 mediates a critical mechanism in TGF-beta signaling that is inactivated by Erk-MAPK in pancreatic cancer cells.
    Ellenrieder V; Buck A; Harth A; Jungert K; Buchholz M; Adler G; Urrutia R; Gress TM
    Gastroenterology; 2004 Aug; 127(2):607-20. PubMed ID: 15300592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cisatracurium regulates the CXCR4/let-7a-5p axis to inhibit colorectal cancer progression by suppressing TGF-β/SMAD2/3 signalling.
    Xia YZ; Shan GF; Yang H; Zha J; Wang L; Chen JM; Zhang XS
    Chem Biol Interact; 2021 Apr; 339():109424. PubMed ID: 33617803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Itraconazole inhibits invasion and migration of pancreatic cancer cells by suppressing TGF-β/SMAD2/3 signaling.
    Chen K; Cheng L; Qian W; Jiang Z; Sun L; Zhao Y; Zhou Y; Zhao L; Wang P; Duan W; Ma Q; Yang W
    Oncol Rep; 2018 Apr; 39(4):1573-1582. PubMed ID: 29484419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rac1b negatively regulates TGF-β1-induced cell motility in pancreatic ductal epithelial cells by suppressing Smad signalling.
    Ungefroren H; Sebens S; Giehl K; Helm O; Groth S; Fändrich F; Röcken C; Sipos B; Lehnert H; Gieseler F
    Oncotarget; 2014 Jan; 5(1):277-90. PubMed ID: 24378395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of miR-133a-3p inhibits fibrosis and proliferation of keloid fibroblasts by regulating IRF5 to inhibit the TGF-β/Smad2 pathway.
    Huang Y; Wang Y; Lin L; Wang P; Jiang L; Liu J; Wang X
    Mol Cell Probes; 2020 Aug; 52():101563. PubMed ID: 32205184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compound Astragalus and Salvia miltiorrhiza extract inhibits cell proliferation, invasion and collagen synthesis in keloid fibroblasts by mediating transforming growth factor-β / Smad pathway.
    He S; Yang Y; Liu X; Huang W; Zhang X; Yang S; Zhang X
    Br J Dermatol; 2012 Mar; 166(3):564-74. PubMed ID: 21967214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.